A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
Journal article
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Journal article
Wei J. et al, (2022), Nat Med
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676
Symptoms and SARS-CoV-2 positivity in the general population in the UK.
Journal article
Vihta K-D. et al, (2021), Clin Infect Dis
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population.
Journal article
Wei J. et al, (2021), Nat Commun, 12
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.
Journal article
Wei J. et al, (2021), Nat Microbiol, 6, 1140 - 1149
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Journal article
Lumley SF. et al, (2021), Clin Infect Dis, 73, e699 - e709
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Journal article
Wei J. et al, (2021)
An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
Journal article
Lumley SF. et al, (2021), Clin Infect Dis
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
Journal article
Eyre DW. et al, (2021), Clin Microbiol Infect
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Working paper
RECOVERY Collaborative Group None., (2021), Lancet, 397, 2049 - 2059
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Working paper
Ahern DJ. et al, (2021)
Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections.
Journal article
Eyre DW. et al, (2021), BMC Infect Dis, 21
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
Journal article
Lumley SF. et al, (2021), N Engl J Med, 384, 533 - 540
High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging.
Journal article
Chen J. et al, (2021), Sci Adv, 7
Decreased blood vessel density and endothelial cell subset dynamics during ageing of the endocrine system.
Journal article
Chen J. et al, (2021), EMBO J, 40
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.
Journal article
Pouwels KB. et al, (2021), Lancet Public Health, 6, e30 - e38
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
Journal article
National SARS-CoV-2 Serology Assay Evaluation Group None., (2020), Lancet Infect Dis, 20, 1390 - 1400
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020.
Journal article
Lumley SF. et al, (2020), Euro Surveill, 25